Peripheral ulcerative keratitis in systemic lupus erythematosus

Article Sidebar

Vol 3 No 2 cover image
PDF
Published: May 30, 1997

Main Article Content

Benalexander A. Pedro, MD
Division of Immunology, Massachusetts Eye and Ear Infirmary, Harvard Medical School
Amyna Merchant, MD
Division of Immunology, Massachusetts Eye and Ear Infirmary, Harvard Medical School
Stephen Foster, MD
Massachusetts Eye and Ear Infirmary, Harvard Medical School

Abstract

Objective
Systemic Lupus Erythematosus (SLE) is a chronic multisystem disease with a wide range of inflammatory involvement in almost every organ of the body. The manifestations of SLE in the eye are as protean as those seen in the other organs of the body. We present the saga of a patient who presented with uncommon but significant manifestations of SLE and discuss its evaluation and management.
Conclusion
This case underscores the uniqueness of SLE as a disease affecting the eye. Careful patient evaluation, as well as a logical stepwise approach to management of the ocular and systemic manifestations prove to be an effective way to prevent the blinding ocular consequences of this disease.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Pedro BA, Merchant A, Foster S. Peripheral ulcerative keratitis in systemic lupus erythematosus. Digit J Ophthalmol. 1997;3(2). Accessed May 1, 2026. https://djo.harvard.edu/index.php/djo/article/view/932
Issue
Vol. 3 No. 2 (1997)
Section
Original Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

Abdou NI, et al. Supressor T-cell abnormality in idiopathic systemic lupus erythematosus. Immunopathol 1976;6:192.

Albert & Jakobiec. Principles and Practice of Ophthalmology. Vol. 5. WB Saunders and Co, 1994.

Aronson AJ, Ordonez, NG, et al. Immune complex deposition in the eye in systemic lupus erythematosus. Arch Intern Med 1979;139:1312.

Blaszcyzyk M, et al. Plasmapheresis in the treatment of systemic lupus erythematosus. Arch Immunol Ther Exp (Warz) 1981;29:769.

Cohen AS, et al. Preliminary criteria for the classification of sytemic lupus erythematosus. Bull Rheum Dis. 21:643, 1971

Copetto J, Lessell S. Retinopathy in systemic lupus retinopathy. Arch Ophthalmol 1977;95:794.

Drosos AA, et al. Unusual eye manifestations in systemic lupus erythematosus patients. Clin Rheumatol 1989;8:49.

Foster CS, Sainz de la Maza M. The Sclera. New York: Springer Verlag Inc, 1994.4

Foster CS. Immunosuppressive therapy in external ocular inflammatory disease. Ophthalmology 1980;87:146.

Foster CS. Ocular surface manifestations of neurological and systemic disease. Int Ophth Clin 1979;19:207.

Gold DH, Morris DA, et al. Ocular systemic findings in systemic lupus erythematosus. Br J Ophth 1972;56:800.

Jackson G, Miller M, et al. Bilateral Internuclear Ophthalmoplegia in Systemic Lupus Erythematosus J Rheumatol 13:1161 1986

Reeves JA. Keratopathy Associated with Systemic Lupus Erythematosus. Medicine 47:337, 1968

Ribrioux A. Sjogren’s Syndrome in Systemic Lupus Erythematosus J Rheumatol 17:201, 1990

Tan EM, Cohen AS, Fries JF, et al. The 1982 Revised Criteria for Classification of Systemic Lupus Erythematosus Arthritis & Rheum 1982;25:1271.